Details for Patent: 10,736,896

✉ Email this page to a colleague

Patent 10,736,896 protects VERQUVO and is included in one NDA.

This patent has eighty-nine patent family members in forty-seven countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Merck Sharp Dohme	VERQUVO	vericiguat	TABLET;ORAL	214377-001	Jan 19, 2021		RX	Yes	No	⤷ Subscribe	⤷ Subscribe	Y	Y			⤷ Subscribe
Merck Sharp Dohme	VERQUVO	vericiguat	TABLET;ORAL	214377-002	Jan 19, 2021		RX	Yes	No	⤷ Subscribe	⤷ Subscribe	Y	Y			⤷ Subscribe
Merck Sharp Dohme	VERQUVO	vericiguat	TABLET;ORAL	214377-003	Jan 19, 2021		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2576547	⤷ Subscribe	PA2021518	Lithuania	⤷ Subscribe
European Patent Office	2576547	⤷ Subscribe	CA 2021 00032	Denmark	⤷ Subscribe
European Patent Office	2576547	⤷ Subscribe	LUC00221	Luxembourg	⤷ Subscribe
European Patent Office	2576547	⤷ Subscribe	122021000048	Germany	⤷ Subscribe
European Patent Office	2576547	⤷ Subscribe	301146	Netherlands	⤷ Subscribe
European Patent Office	2576547	⤷ Subscribe	2021C/553	Belgium	⤷ Subscribe
European Patent Office	2576547	⤷ Subscribe	C02576547/01	Switzerland	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration